Goldman Sachs Neutral on Medical Technology; COV, NUVA, ZMH Top Ideas

September 30, 2009 7:18 AM EDT Send to a Friend
Get Alerts COV Hot Sheet
Price: $87.41 -2.06%

Rating Summary:
    12 Buy, 9 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 29 | Down: 28 | New: 24
Trade COV Now!
Join SI Premium – FREE
Goldman Sachs initiates coverage on Medical Technology with a Neutral view. The firm is Bullish on supplies, Neutral on ortho, and Cautious on cardio

  • The firm is rating Covidien plc (NYSE: COV) with a Conviction Buy List rating and $52 price target
  • NuVasive, Inc. (Nasdaq: NUVA) Buy $40 price target
  • Zimmer Holdings Inc. (NYSE: ZMH) Buy $54 price target
  • Stryker Corp. (NYSE: SYK) Neutral $54 price target.
  • Baxter International Inc. (NYSE: BAX) Neutral $67 price target
  • Hospira Inc. (NYSE: HSP) Neutral $51 price target
  • Boston Scientific Corporation (NYSE: BSX) Neutral $13 price target
  • Medtronic, Inc. (NYSE: MDT) Neutral $43 price target
  • Edwards Lifesciences Corp. (NYSE: EW) Netural $79 price target
  • St. Jude Medical Inc. (NYSE: STJ) Sell $41 price target
  • Becton, Dickinson and Company (NYSE: BDX) Sell $69 price target.

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Goldman Sachs Conviction Buy List

Add Your Comment